UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 41

Sortiert nach

Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Main Text

Current vascular pharmacology, 2019-01, Vol.17 (5), p.498

2019

Volltextzugriff (PDF)

Severe gestational hypertriglyceridemia: A practical approach for clinicians

Obstetric Medicine, 2015-12, Vol.8 (4), p.158-167

2015

Volltextzugriff (PDF)

Postprandial Hypertriglyceridaemia Revisited in the Era of Non-fasting Lipid Profiles: Executive Summary of a 2019 Expert Panel Statement

Current vascular pharmacology, 2019-01, Vol.17 (5), p.538

2019

Volltextzugriff (PDF)

Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Narrative Review

Current vascular pharmacology, 2019-01, Vol.17 (5), p.515

2019

Volltextzugriff (PDF)

Comparison of Three Methods for LDLC Calculation for Cardiovascular Disease Risk Categorisation in Three Distinct Patient Populations

Canadian journal of cardiology, 2023-05, Vol.39 (5), p.668-677

2023

Volltextzugriff (PDF)

Relative effect of hypertriglyceridemia on non-HDLC and apolipoprotein B as cardiovascular disease risk markers

Journal of clinical lipidology, 2020-11, Vol.14 (6), p.825-836

2020

Volltextzugriff (PDF)

A More Atherogenic Lipoprotein Status Is Present in Adults With Type 2 Diabetes Mellitus Than in Those Without With Equivalent Degrees of Hypertriglyceridemia

Canadian journal of diabetes, 2022-07, Vol.46 (5), p.480-486

2022

Volltextzugriff (PDF)

Metformin and carotid intima‐media thickness in never‐smokers with type 1 diabetes: The REMOVAL trial

Diabetes, obesity & metabolism, 2021-06, Vol.23 (6), p.1371-1378

2021

Volltextzugriff (PDF)

The anti‐adipogenic effect of peripheral blood mononuclear cells is absent with PCSK9 loss‐of‐function variants

Obesity (Silver Spring, Md.), 2016-11, Vol.24 (11), p.2384-2391

2016

Volltextzugriff (PDF)

Interactions of commonly used dietary supplements with cardiovascular drugs: a systematic review

Systematic reviews, 2012-05, Vol.1 (1), p.26-26, Article 26

2012

Volltextzugriff (PDF)

Calculated Non-HDL Cholesterol Includes Cholesterol in Larger Triglyceride-Rich Lipoproteins in Hypertriglyceridemia

Journal of the Endocrine Society, 2020-01, Vol.4 (1), p.bvz010-bvz010

2020

Volltextzugriff (PDF)

The contribution of PCSK9 levels to the phenotypic severity of familial hypercholesterolemia is independent of LDL receptor genotype

Metabolism, clinical and experimental, 2015-11, Vol.64 (11), p.1541-1547

2015

Volltextzugriff (PDF)

The anti‐adipogenic effect of peripheral blood mononuclear cells is absent with PCSK 9 loss‐of‐function variants

Obesity (Silver Spring, Md.), 2016-11, Vol.24 (11), p.2384-2391

2016

Volltextzugriff (PDF)

Efficacy and safety of a new hydroxymethylglutaryl-coenzyme A reductase inhibitor, atorvastatin, in patients with combined hyperlipidemia: comparison with fenofibrate

Arteriosclerosis, thrombosis, and vascular biology, 1997-09, Vol.17 (9), p.1793

1997

Volltextzugriff (PDF)

Circulating Soluble Low Density Lipoprotein Receptor Levels in Heterozygous Familial Hypercholesterolemia Subjects Before and After Statin Therapy

Atherosclerosis. Supplements, 2018-06, Vol.32, p.60-61

2018

Volltextzugriff (PDF)

Underrecognition of chylomicronemia as a cause of acute pancreatitis

Canadian Medical Association journal (CMAJ), 1992-12, Vol.147 (12), p.1806

1992

Volltextzugriff (PDF)

Evidence for bimodal distribution of breast carcinoma ER and PgR values quantitated by enzyme immunoassay

European journal of cancer (1990), 1993, Vol.29 (9), p.1293-1297

1993

Volltextzugriff (PDF)

The standardization of estrogen receptors

The Journal of steroid biochemistry and molecular biology, 1993-05, Vol.45 (5), p.367-373

1993

Volltextzugriff (PDF)

Inter-laboratory quality control of estrogen and progesterone receptor assays in breast cancer tissue using lyophilised cytosols

Clinical biochemistry, 1985-02, Vol.18 (1), p.20-26

1985

Volltextzugriff (PDF)

The effect of cimetidine and ranitidine on serum high density lipoprotein subfractions

Atherosclerosis, 1985-11, Vol.57 (2), p.159-162

1985

Volltextzugriff (PDF)

The value of urinary chloride measurement in distinguishing surreptitious vomiting from Bartter's syndrome

Clinical biochemistry, 1983-08, Vol.16 (4), p.263-265

1983

Volltextzugriff (PDF)

Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease

The New England journal of medicine, 2013-12, Vol.369 (26), p.2492-2503

2013

Volltextzugriff (PDF)

Into the abyss: diabetes process of care indicators and outcomes of defaulters from a Canadian tertiary care multidisciplinary diabetes clinic

BMC health services research, 2013-08, Vol.13 (1), p.303-303, Article 303

2013

Volltextzugriff (PDF)

Using a Structured Discharge Letter Template to Improve Communication During the Transition from a Specialized Outpatient Diabetes Clinic to a Primary Care Physician

Canadian journal of diabetes, 2015-12, Vol.39 (6), p.457-466

2015

Volltextzugriff (PDF)

Metformin in adults with type 1 diabetes: Design and methods of REducing with MetfOrmin Vascular Adverse Lesions (REMOVAL): An international multicentre trial

Diabetes, obesity & metabolism, 2017-04, Vol.19 (4), p.509-516

2017

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(40)
Tagungsberichte
(1)

Sprache

Englisch
(41)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Main Text

Severe gestational hypertriglyceridemia: A practical approach for clinicians

Postprandial Hypertriglyceridaemia Revisited in the Era of Non-fasting Lipid Profiles: Executive Summary of a 2019 Expert Panel Statement

Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Narrative Review

Comparison of Three Methods for LDLC Calculation for Cardiovascular Disease Risk Categorisation in Three Distinct Patient Populations

Relative effect of hypertriglyceridemia on non-HDLC and apolipoprotein B as cardiovascular disease risk markers

A More Atherogenic Lipoprotein Status Is Present in Adults With Type 2 Diabetes Mellitus Than in Those Without With Equivalent Degrees of Hypertriglyceridemia

Metformin and carotid intima‐media thickness in never‐smokers with type 1 diabetes: The REMOVAL trial

The anti‐adipogenic effect of peripheral blood mononuclear cells is absent with PCSK9 loss‐of‐function variants

Interactions of commonly used dietary supplements with cardiovascular drugs: a systematic review

Calculated Non-HDL Cholesterol Includes Cholesterol in Larger Triglyceride-Rich Lipoproteins in Hypertriglyceridemia

The contribution of PCSK9 levels to the phenotypic severity of familial hypercholesterolemia is independent of LDL receptor genotype

The anti‐adipogenic effect of peripheral blood mononuclear cells is absent with PCSK 9 loss‐of‐function variants

Efficacy and safety of a new hydroxymethylglutaryl-coenzyme A reductase inhibitor, atorvastatin, in patients with combined hyperlipidemia: comparison with fenofibrate

Circulating Soluble Low Density Lipoprotein Receptor Levels in Heterozygous Familial Hypercholesterolemia Subjects Before and After Statin Therapy

Underrecognition of chylomicronemia as a cause of acute pancreatitis

Evidence for bimodal distribution of breast carcinoma ER and PgR values quantitated by enzyme immunoassay

The standardization of estrogen receptors

Inter-laboratory quality control of estrogen and progesterone receptor assays in breast cancer tissue using lyophilised cytosols

The effect of cimetidine and ranitidine on serum high density lipoprotein subfractions

The value of urinary chloride measurement in distinguishing surreptitious vomiting from Bartter's syndrome

Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease

Into the abyss: diabetes process of care indicators and outcomes of defaulters from a Canadian tertiary care multidisciplinary diabetes clinic

Using a Structured Discharge Letter Template to Improve Communication During the Transition from a Specialized Outpatient Diabetes Clinic to a Primary Care Physician

Metformin in adults with type 1 diabetes: Design and methods of REducing with MetfOrmin Vascular Adverse Lesions (REMOVAL): An international multicentre trial

Suchergebnisse filtern